Ethambutol Toxicity Exacerbating The Phenotype Of CMT2A2

Muscle and Nerve

Volumn 48, Issue 1, 2013, Pages 140-144

  Fonkem, Ekokobe ^a   Skordilis, Monica A ^b   Binkley, Elaine M ^b   Raymer, David S ^b   Epstein, Avrom ^a   Arnold, W David ^b   Kissel, John T ^b   Lawson, Victoria H ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

CMT; Ethambutol; Mitochondria; Mitofusin; Neurotoxicity

Indexed keywords

AZITHROMYCIN; ETHAMBUTOL; MITOFUSIN 2; RIFABUTIN;

AGED; ARTICLE; BRONCHIECTASIS; CASE REPORT; CMT2A2 GENE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GAIT DISORDER; GENE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG NODULE; MOTOR UNIT POTENTIAL; MUSCLE ACTION POTENTIAL; MYCOBACTERIUM INTRACELLULARE AVIUM; NERVE POTENTIAL; NEUROLOGIC EXAMINATION; OPTIC NERVE ATROPHY; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; TREATMENT DURATION; VISUAL FIELD; VOCAL CORD PARALYSIS; WEAKNESS;

CHARCOT-MARIE-TOOTH DISEASE; ETHAMBUTOL; FEMALE; HUMANS; MIDDLE AGED; PHENOTYPE;

EID: 84879550022     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23766     Document Type: Article

References (30)

1. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali E, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004;36:449-451.
2. Lawson VH, Graham BV, Flanigan KM. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene. Neurology 2005;65:197-204.
3. Chen H, Chan DC. Mitochondrial dynamics- fusion, fission, movement, and mitophagy- in neurodegenerative diseases. Hum Mol Genet 2009;18:169-176.
4. Chen H, Chan DC. Physiological functions of mitochondrial fusion. Ann N Y Acad Sci 2010;1201:21-25.
5. Zuchner S, De Jonghe P, Jordanova A, Claeys KG, Guerguelt-cheva V, Cherninkova S, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol 2006;59:276-281.
6. Weiden PL, Wright SE. Vincristine neurotoxicity. N Engl J Med 1972;286:1369-1370.
7. Weimer HL, Podwall D. Medication-induced exacerbation of neuropathy in Charcot Mare Tooth disease. J Neurol Sci 2006;242:47-54.
8. Guillet V, Chevrollier A, Cassereau J, Letournel F, Gueguen N, Richard L, et al. Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity. Mitochondrion 2010;10:115-124.
9. AMA Department of Drugs AMA Department of Drugs: AMA drug evaluations subscriptions. Chicago, IL: American Medical Association; 1986.
10. Kijima K, Numakura C, Izumino H, Umetsu K, Nezu A, Shiiki T, et al. Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Hum Genet 2005;116:23-27.
11. Amiott EA, Lott P, Soto J, Kang PB, DiMauro S, Abel ED, et al. Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations. Exp Neurol 2008;211:115-127.
12. Feely SME, Laura M, Siskind CE, Sottile S, Davis M, Gibbons VS, et al. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology 2011;76:1690-1696.
13. Voo I, Allf B, Udar N, et al. Hereditary motor and sensory neuropathy type VI with optic atrophy. Am J Ophthalmol 2003;136:670-677.
14. Cartoni R, Martinou JC. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A. Exp Neurol 2009;218:268-273.
15. Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiere A, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008;131:338-351.
16. Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008;131:329-337.
17. Song Z, Ghochani M, McCaffery JM, Frey TG, Chan DC. Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell 2009;20:3525-3532.
18. Misko A, Jiang S, Wegorzewska I, Milbrandt J, Baloh RH. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton Complex. J Neurosci 2010;30:4232-4240.
19. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 2004;23:53-89.
20. Ikeda A, Ikeda T, Ikeda N, Kawakami Y, Mimura O. Leber's hereditary optic neuropathy precipitated by ethambutol. Jpn J Ophthalmol 2006;50:280-283.
21. Brown MD, Sun F, Wallace DC. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet 1997;60:381-387.
22. Sadun AA, Wang MY. Ethambutol optic neuropathy: how we can prevent 100, 000 new cases of blindness each year. J Neuroophthalmol 2008;28:265-268.
23. Lee EJ, Kim SJ, Choung HK, Kim JH, Yu YS. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. J Neuroophthalmol 2008;28:269-277.
24. Nair VS, LeBrun M, Kass I. Peripheral neuropathy associated with ethambutol. Chest 1980;77:98-100.
25. Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005;64:1209-1214.
26. Kasperbauer SH, Daley CL. Diagnosis and treatment of infections due to Mycobacterium avium complex. Semin Respir Crit Care Med 2008;29:569-576.
27. Lawson VH, Gharibshahi S. Alphabet soup: making sense of genetic testing in CMT. Semin Neurol 2010;30:373-386.
28. Niemann A, Ruegg M, La Padula V, Schenone A, Suter U. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol 2005;170:1067-1078.
29. Sevilla T, Jaijo T, Nauffal D, Collado D, chumillas MJ, Vilchez JJ, et al. Vocal cord paresis and diaphragmantic dysfunction are severe and frequent symptoms of GDAP-1 associated neuropathy. Brain 2008;131:3051-3061.
30. Hirano M, DiMauro S. Leber hereditary optic neuropathy: biochemical lights in a blurry scenario. Arch Neurol 2005;62:711.